Literature DB >> 24812280

Impaired local regulation of ryanodine receptor type 2 by protein phosphatase 1 promotes atrial fibrillation.

David Y Chiang1, Na Li2, Qiongling Wang2, Katherina M Alsina2, Ann P Quick2, Julia O Reynolds2, Guoliang Wang3, Darlene Skapura2, Niels Voigt4, Dobromir Dobrev4, Xander H T Wehrens5.   

Abstract

AIMS: Altered Ca(2+) handling in atrial fibrillation (AF) has been associated with dysregulated protein phosphatase 1 (PP1) and subcellular heterogeneities in protein phosphorylation, but the underlying mechanisms remain unclear. This is due to a lack of investigation into the local, rather than global, regulation of PP1 on different subcellular targets such as ryanodine receptor type 2 (RyR2), especially in AF. METHODS AND
RESULTS: We tested the hypothesis that impaired local regulation of PP1 causes RyR2 hyperphosphorylation thereby promoting AF susceptibility. To specifically disrupt PP1's local regulation of RyR2, we used the spinophilin knockout (Sp(-/-)) mice (Mus musculus) since PP1 is targeted to RyR2 via spinophilin. Without spinophilin, the interaction between PP1 and RyR2 was reduced by 64%, while RyR2 phosphorylation was increased by 43% at serine (S)2814 but unchanged at S2808. Lipid bilayer experiments revealed that single RyR2 channels isolated from Sp(-/-) hearts had an increased open probability. Likewise, Ca(2+) spark frequency normalized to sarcoplasmic reticulum Ca(2+) content was also enhanced in Sp(-/-) atrial myocytes, but normalized by Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) inhibitors KN-93 and AIP and also by genetic inhibition of RyR2 S2814 phosphorylation. Finally, Sp(-/-) mice exhibited increased atrial ectopy and susceptibility to pacing-induced AF, both of which were also prevented by the RyR2 S2814A mutation.
CONCLUSION: PP1 regulates RyR2 locally by counteracting CaMKII phosphorylation of RyR2. Decreased local PP1 regulation of RyR2 contributes to RyR2 hyperactivity and promotes AF susceptibility. This represents a novel mechanism for subcellular modulation of calcium channels and may represent a potential drug target of AF. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2014. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Atrial fibrillation; Ca2+/calmodulin-dependent kinase II; Protein phosphatase 1; Ryanodine receptor type 2; Spinophilin

Mesh:

Substances:

Year:  2014        PMID: 24812280      PMCID: PMC4133595          DOI: 10.1093/cvr/cvu123

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  38 in total

1.  Type 1 phosphatase, a negative regulator of cardiac function.

Authors:  Andrew N Carr; Albrecht G Schmidt; Yoichi Suzuki; Federica del Monte; Yoji Sato; Carita Lanner; Kristine Breeden; Shao-Ling Jing; Patrick B Allen; Paul Greengard; Atsuko Yatani; Brian D Hoit; Ingrid L Grupp; Roger J Hajjar; Anna A DePaoli-Roach; Evangelia G Kranias
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

2.  PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts.

Authors:  S O Marx; S Reiken; Y Hisamatsu; T Jayaraman; D Burkhoff; N Rosemblit; A R Marks
Journal:  Cell       Date:  2000-05-12       Impact factor: 41.582

3.  Protein phosphatases decrease sarcoplasmic reticulum calcium content by stimulating calcium release in cardiac myocytes.

Authors:  Dmitry Terentyev; Serge Viatchenko-Karpinski; Inna Gyorke; Radmila Terentyeva; Sandor Gyorke
Journal:  J Physiol       Date:  2003-08-01       Impact factor: 5.182

4.  Dynamic modulation of excitation-contraction coupling by protein phosphatases in rat ventricular myocytes.

Authors:  W H duBell; W J Lederer; T B Rogers
Journal:  J Physiol       Date:  1996-06-15       Impact factor: 5.182

Review 5.  The PP1 binding code: a molecular-lego strategy that governs specificity.

Authors:  Ewald Heroes; Bart Lesage; Janina Görnemann; Monique Beullens; Luc Van Meervelt; Mathieu Bollen
Journal:  FEBS J       Date:  2012-03-21       Impact factor: 5.542

6.  Inhibition of CaMKII phosphorylation of RyR2 prevents induction of atrial fibrillation in FKBP12.6 knockout mice.

Authors:  Na Li; Tiannan Wang; Wei Wang; Michael J Cutler; Qiongling Wang; Niels Voigt; David S Rosenbaum; Dobromir Dobrev; Xander H T Wehrens
Journal:  Circ Res       Date:  2011-12-08       Impact factor: 17.367

7.  Defective cardiac ryanodine receptor regulation during atrial fibrillation.

Authors:  John A Vest; Xander H T Wehrens; Steven R Reiken; Stephan E Lehnart; Dobromir Dobrev; Parag Chandra; Peter Danilo; Ursula Ravens; Michael R Rosen; Andrew R Marks
Journal:  Circulation       Date:  2005-04-26       Impact factor: 29.690

8.  CaMKII-dependent diastolic SR Ca2+ leak and elevated diastolic Ca2+ levels in right atrial myocardium of patients with atrial fibrillation.

Authors:  Stefan Neef; Nataliya Dybkova; Samuel Sossalla; Katharina R Ort; Nina Fluschnik; Kay Neumann; Ralf Seipelt; Friedrich A Schöndube; Gerd Hasenfuss; Lars S Maier
Journal:  Circ Res       Date:  2010-01-07       Impact factor: 17.367

9.  miR-1 overexpression enhances Ca(2+) release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKII-dependent hyperphosphorylation of RyR2.

Authors:  Dmitry Terentyev; Andriy E Belevych; Radmila Terentyeva; Mickey M Martin; Geraldine E Malana; Donald E Kuhn; Maha Abdellatif; David S Feldman; Terry S Elton; Sandor Györke
Journal:  Circ Res       Date:  2009-01-08       Impact factor: 17.367

10.  Structural and functional characterization of ryanodine receptor-natrin toxin interaction.

Authors:  Qiang Zhou; Qiong-Ling Wang; Xing Meng; Yuyan Shu; Tao Jiang; Terence Wagenknecht; Chang-Cheng Yin; Sen-Fang Sui; Zheng Liu
Journal:  Biophys J       Date:  2008-07-25       Impact factor: 4.033

View more
  30 in total

Review 1.  Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy: A Translational Perspective.

Authors:  Stanley Nattel; Jordi Heijman; Liping Zhou; Dobromir Dobrev
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

2.  Dysfunction of the β2-spectrin-based pathway in human heart failure.

Authors:  Sakima A Smith; Langston D Hughes; Crystal F Kline; Amber N Kempton; Lisa E Dorn; Jerry Curran; Michael Makara; Tyler R Webb; Patrick Wright; Niels Voigt; Philip F Binkley; Paul M L Janssen; Ahmet Kilic; Cynthia A Carnes; Dobromir Dobrev; Matthew N Rasband; Thomas J Hund; Peter J Mohler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-04-22       Impact factor: 4.733

Review 3.  Serine/Threonine Phosphatases in Atrial Fibrillation.

Authors:  Jordi Heijman; Shokoufeh Ghezelbash; Xander H T Wehrens; Dobromir Dobrev
Journal:  J Mol Cell Cardiol       Date:  2017-01-07       Impact factor: 5.000

Review 4.  Calcium-mediated cellular triggered activity in atrial fibrillation.

Authors:  Dobromir Dobrev; Xander H T Wehrens
Journal:  J Physiol       Date:  2017-03-22       Impact factor: 5.182

Review 5.  Regulation of sarcoplasmic reticulum Ca2+ release by serine-threonine phosphatases in the heart.

Authors:  Dmitry Terentyev; Shanna Hamilton
Journal:  J Mol Cell Cardiol       Date:  2016-08-29       Impact factor: 5.000

6.  Ca2+/calmodulin-dependent kinase II-dependent regulation of atrial myocyte late Na+ current, Ca2+ cycling, and excitability: a mathematical modeling study.

Authors:  Birce Onal; Daniel Gratz; Thomas J Hund
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-08-25       Impact factor: 4.733

Review 7.  The role of βII spectrin in cardiac health and disease.

Authors:  Mohamed H Derbala; Aaron S Guo; Peter J Mohler; Sakima A Smith
Journal:  Life Sci       Date:  2017-11-09       Impact factor: 5.037

8.  Loss of Protein Phosphatase 1 Regulatory Subunit PPP1R3A Promotes Atrial Fibrillation.

Authors:  Katherina M Alsina; Mohit Hulsurkar; Sören Brandenburg; Daniel Kownatzki-Danger; Christof Lenz; Henning Urlaub; Issam Abu-Taha; Markus Kamler; David Y Chiang; Satadru K Lahiri; Julia O Reynolds; Ann P Quick; Larry Scott; Tarah A Word; Maria D Gelves; Albert J R Heck; Na Li; Dobromir Dobrev; Stephan E Lehnart; Xander H T Wehrens
Journal:  Circulation       Date:  2019-06-12       Impact factor: 29.690

9.  STAT3: a link between CaMKII-βIV-spectrin and maladaptive remodeling?

Authors:  Mohit Hulsurkar; Ann P Quick; Xander Ht Wehrens
Journal:  J Clin Invest       Date:  2018-11-12       Impact factor: 14.808

Review 10.  Regulating the regulator: Insights into the cardiac protein phosphatase 1 interactome.

Authors:  David Y Chiang; Albert J R Heck; Dobromir Dobrev; Xander H T Wehrens
Journal:  J Mol Cell Cardiol       Date:  2016-09-20       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.